tiprankstipranks
Advertisement
Advertisement

TCRT Stock Latest News

Alaunos Reports Positive Preclinical Data for Obesity Candidate
Company AnnouncementsAlaunos Reports Positive Preclinical Data for Obesity Candidate
1M ago
8K
TCRT
Alaunos Therapeutics reports ‘positive’ proof-of-concept data for ALN1003
PremiumThe Fly
Alaunos Therapeutics reports ‘positive’ proof-of-concept data for ALN1003
1M ago
TCRT
Alaunos Updates Governance, Ends Cantor Advisory Agreement
PremiumCompany Announcements
Alaunos Updates Governance, Ends Cantor Advisory Agreement
3M ago
8K
TCRT
Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer
PremiumCompany Announcements
Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer
3M ago
8K
TCRT
Alaunos Therapeutics files to sell 327,740 shares of common for holders
PremiumThe Fly
Alaunos Therapeutics files to sell 327,740 shares of common for holders
5M ago
TCRT
Alaunos Therapeutics files $50M mixed securities shelf
PremiumThe FlyAlaunos Therapeutics files $50M mixed securities shelf
8M ago
TCRT
Alaunos Therapeutics Regains Nasdaq Compliance
Premium
Company Announcements
Alaunos Therapeutics Regains Nasdaq Compliance
8M ago
8K
TCRT
Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
Premium
Company Announcements
Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
8M ago
TCRT
Alaunos Therapeutics’ Pediatric Brain Tumor Study Update: Implications and Insights
PremiumCompany Announcements
Alaunos Therapeutics’ Pediatric Brain Tumor Study Update: Implications and Insights
8M ago
TCRT
Alaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment
PremiumCompany Announcements
Alaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment
8M ago
TCRT
Alaunos Therapeutics’ TCR-T Study Update: Implications for Investors
PremiumCompany Announcements
Alaunos Therapeutics’ TCR-T Study Update: Implications for Investors
8M ago
TCRT
Alaunos Therapeutics Announces Departure of Melinda Lackey
PremiumCompany Announcements
Alaunos Therapeutics Announces Departure of Melinda Lackey
9M ago
8K
TCRT
Alaunos Therapeutics Holds Annual Stockholders Meeting
PremiumCompany AnnouncementsAlaunos Therapeutics Holds Annual Stockholders Meeting
9M ago
8K
TCRT
Alaunos Therapeutics Appoints Holger Weis as New CEO
Premium
Company Announcements
Alaunos Therapeutics Appoints Holger Weis as New CEO
9M ago
8K
TCRT
Alaunos Therapeutics Raises $850,000 in Private Offering
Premium
Company Announcements
Alaunos Therapeutics Raises $850,000 in Private Offering
9M ago
8K
TCRT
Alaunos Therapeutics Closes Registered Direct Offering
PremiumCompany Announcements
Alaunos Therapeutics Closes Registered Direct Offering
9M ago
8K
TCRT
Alaunos prices 610,399 shares at $3.36 in registered direct offering
PremiumThe Fly
Alaunos prices 610,399 shares at $3.36 in registered direct offering
9M ago
TCRT
Alaunos Therapeutics Amends Warrant Agreement with Mast Hill
PremiumCompany Announcements
Alaunos Therapeutics Amends Warrant Agreement with Mast Hill
10M ago
8K
TCRT
Alaunos Therapeutics Secures $25M Equity Purchase Deal
PremiumCompany Announcements
Alaunos Therapeutics Secures $25M Equity Purchase Deal
11M ago
8K
TCRT
PMGC Capital announces filing to report 5.09% stake in Alaunos Therapeutics
PremiumThe FlyPMGC Capital announces filing to report 5.09% stake in Alaunos Therapeutics
11M ago
ELAB
TCRT
Alaunos Therapeutics Board Opts for Equity Compensation
Premium
Company Announcements
Alaunos Therapeutics Board Opts for Equity Compensation
12M ago
8K
TCRT
Five new option listings and option delistings on January 21st
Premium
The Fly
Five new option listings and option delistings on January 21st
1y ago
SQ
ADN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >